Eversana has announced the appointment of Bhaskar Sambasivan as president, patient services and chief strategy officer of the company; this follows a busy round of appointments earlier this year bringing in top executives from AmerisourceBergen, Cardinal Health and inVentiv Health […]
Read MoreSaying that “This new location will give us the space and ability to support future pharmaceutical client programs,” founder and CEO Nitin Sahney has announced a planned $52-million investment in the site, which is just across the state border from […]
Read More
Healthwell Foundation, one of the leading 505(c)3 charities that manage patient assistance programs (PAPs) for the pharma industry, has opened a contact center in Frederick, MD, to manage queries and patient support. The facility will have 75 dedicated case managers; […]
Read MoreThe 340b program, under which hospitals qualify for significant discounts on drug prices if they provide sufficient public aid to the indigent, has been a growing sore point for the pharma industry, mostly because what started out as a small, […]
Read MoreOne of the things Facebook has been famous for is its ethos to “move fast and break things;” at Eversana, that theme could be modified to “move fast and build things.” In rapid succession since its founding less than two […]
Read MoreThe business of digitizing patient records for billing, practice management and (sometimes) better patient care is important to the life sciences industry because prescription choices flow out of the data and represent an important touchpoint for drug marketers. According to […]
Read MoreAs it kicks off its annual Specialty Pharmacy Summit (Las Vegas, Apr. 29-May 2), Asembia has announced a new offering that provides a level of patient support to drugs that typically are not budgeted for the high-touch, high-cost services of […]
Read MoreEnvoyHealth, the independently operated subsidiary of leading specialty pharmacy, Diplomat, has added partnerships with two web-based services in the past month. Combined, the services promise to improve speed to therapy and adherence to drug regimens, in the near term, and […]
Read MoreOne thing’s for sure. There has perhaps never been a better time to be strategizing how to devise patents, distribution channels, rebates and commercial arrangements to maximize revenue or market share in the US drug market. The current hue and […]
Read MoreAccording to a report in FiercePharmaMarketing, J&J’s Janssen unit might be the first US pharma company to include price information in its TV advertising for Xarelto, a widely used blood thinner. The ads, which include a $448 list price for […]
Read More